GHRS GHRS
Company Profile ↓Company Overview
GHRS (GHRS) is a publicly traded company listed on with a market capitalization of $1.81B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.18.
Recent Developments
- 5-Year Trend Long-term compounding — profit CAGR -38.3%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | -38.30% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +116.74% |
| 6 Months: | +82.98% |
| 3 Months: | +36.89% |
| 1 Month: | +8.33% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)62.75 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -38.3% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | 12.75M | 14.69M | 16.54M | 16.70M | 18.75M |
| Operating Income | - | -12.75M | -14.69M | -16.54M | -16.70M | -18.75M |
| EBITDA | - | -10.73M | -9.20M | -13.92M | -14.04M | -18.87M |
| Interest Expense | - | 10.00K | 9.00K | 8.00K | 8.00K | 6.00K |
| Pretax Income | - | -10.81M | -9.29M | -14.02M | -14.14M | -18.97M |
| Tax Provision | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | - | -10.81M | -9.29M | -14.02M | -14.14M | -18.97M |
| Diluted EPS | - | -0.19 | -0.15 | -0.23 | - | -0.31 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 30.68M | 41.22M | 50.25M | 60.68M |
| Operating Income | -30.68M | -41.22M | -50.25M | -60.68M |
| EBITDA | -22.41M | -35.21M | -38.60M | -47.89M |
| Interest Expense | 0 | 63.00K | 48.00K | 35.00K |
| Pretax Income | -22.46M | -35.59M | -38.96M | -48.26M |
| Tax Provision | 0 | 0 | 0 | 0 |
| Net Income | -22.46M | -35.59M | -38.96M | -48.26M |
| Diluted EPS | -0.43 | -0.68 | -0.75 | -0.79 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 254.36M | 226.30M | 188.27M | 288.23M |
| Current Assets | - | 168.54M | 164.09M | 154.22M | 285.98M |
| Cash & Equivalents | - | 165.96M | 78.42M | 100.79M | 246.25M |
| Inventory | - | - | - | - | - |
| Receivables | - | 90.00K | 297.00K | 1.73M | 1.29M |
| Total Liabilities | - | 4.55M | 7.33M | 9.32M | 8.53M |
| Current Liabilities | - | 4.55M | 6.70M | 8.95M | 8.38M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 0 | 974.00K | 624.00K | 512.00K |
| Total Equity | - | 249.82M | 218.97M | 178.95M | 279.70M |
| Shares Outstanding | - | 52.02M | 52.03M | 52.03M | 62.03M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -26.20M | -33.34M | -42.28M | -43.55M |
| Investing Cash Flow | - | -84.69M | -54.10M | 65.14M | 46.17M |
| Financing Cash Flow | - | 0 | -204.00K | -304.00K | 139.65M |
| Capital Expenditure | - | -67.00K | -100.00K | -49.00K | -121.00K |
| Free Cash Flow | - | -26.27M | -33.44M | -42.33M | -43.67M |
| Net Change in Cash | - | -110.89M | -87.64M | 22.55M | 142.27M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | -9.0% | -16.3% | -21.8% | -17.3% |
| ROCE % | -12.3% | -18.8% | -28.0% | -21.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GHRS
Is GH Research (GHRS) Trading At A Premium To Fair Value? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOYzNIa0twTVlQS0NDbjJGelQ5em42RWlVZE1zNFhuTXZycGJpR05mSlE5WUhuZUxhR3V5R2paN1RQdWxXSWtMWHRCNkVtcC1HNFV1VkhzcGhoMUxYVWFocHpZcU9hREJUaWVCa1dXMHZuNmVHNnpxa3FpNWw2dEpYcVJ5R1NTbmxPUlkxQU…
GH Research Plc Actuals & Estimates (NASDAQ:GHRS) - TradingView
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNSlJuTENHcVFkN0lFbU5IU0JIajAtbE9qS2l5Qm1fUHlDeUllOHBNVU9KcXRYa1FmcmhyR25iMnhnSUJjMkxfeVhJelJwMEVya1dVZ1lXUlBxUktOTk14Qy1IOEYzOGRYTTZuZUp4NnQ1aFNPLWYtSXczb0ZiZDE5azRGdjZQUQ?oc=5" t…
GH Research (GHRS) Stock Looks Stretched On Its 111% YTD Run - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOMHVEYmxvNEdDVjNheVhQQ210V1J2M3FmSG44ZlBqZHlSVldpTk92OGJYXzJTRXgzbEdDOHNwU25keEdvTzZUWk9zRnhLNFZsMDVBWUFmLXR2a1lEdG1yc0h5TlpiWTU0RG1pVHQ0SmJ3SFh2bl9SSS1wY0pGc1c5MzcxRGtXclRWckF0bX…
Is GH Research (GHRS) Fully Valued Following Its Share Price Surge? - Sahm
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOTTJzWHBuREhSN29RMThIcGk5Q3JzZzZNVVNYWVM5TnhCcU1VeFl3WXpxeEYtVi1fZURMajFCSlJtbnA1bjc0b1UzOXRnVndEZ2RMM2NLVUFHemtGeGs3SFh6RExjenEwU3U1RkJBcmFSOVJoS2RZYV9Ka3AzQU1GaENVcVFDLWlKWmd4aV…
Why Is GHRS Stock Rising Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNRVltaGRwdzRibHh3Ull4M0dMcWRfNFBtUC1DVXZaYkgzaWo4bjlZM0dhNUpRUWNYMmhORm9NdjhEX2VzOGdZLUNsOERCeDVGd284S0p2UmxZS1J0WkxxN3VvVkZhcG1ZdXVoTm85MFp5V0prRkhJeGxuUlZuV3RmM0RuRU04MDR4TE5Id3…
White House mental illness order aligns with GH Research's 2026 Phase 3 plan - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMXFab2tJZGpMNldyUk5VSy11Z0loOVBmN0pvNFN3ZVYxMGg5RXgzRjZSd3BtZUZPVmVEN25tbXA2OFRyWTZ2V2ZwbTE1WlJ6eWpKamR0dkJWalNTenlJU0dnZkhVNVhpcVplaXQ5LVFvTXNPSXd4THpySDFWM2dYVEg5MURoVWZFMy02aG…
GHRS — Frequently Asked Questions
What is the current share price of GHRS?
As of 2026-08-05 17:25 PDT, GHRS trades at $29.13 on NASDAQ/NYSE. Its 52-week range is $11.80 to $29.13.
What is the market capitalisation of GHRS?
GHRS has a market capitalisation of $1.81B on NASDAQ/NYSE.
What is the P/E ratio of GHRS?
GHRS trades at a trailing price-to-earnings (P/E) ratio of -36.87. Its price-to-book (P/B) ratio is 6.46.
What is the return on equity (ROE) of GHRS?
GHRS has a return on equity (ROE) of -17.25%. Its return on capital employed (ROCE) is -21.68%.
Is GHRS a good stock to buy?
This page provides a data-driven analysis of GHRS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.